Alzheimer’s disease neuropathological change in younger individuals with IDH-mutant glioma
Open Access
- 6 January 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 7 (1) , vdaf057
Abstract
Background: With aging populations, the incidence of brain tumors and neurodegenerative diseases is rising. Recently, Alzheimer’s disease neuropathological change (ADNC) has been documented in the tumor-adjacent cortex of 50% of patients with glioblastoma, with isolated hyperphosphorylated tau (pTau) deposits already present in younger individuals. This study extends ADNC screening to younger patients with IDH-mutant glioma, focusing on pTau and amyloid beta (Abeta) deposits, microglial activation, and amyloid precursor protein (APP) expression in the context of cortical tumor cell infiltration. Material and Methods: We included 85 patients with IDH-mutant gliomas (37 astrocytomas, median age: 39; 48 oligodendrogliomas, median age: 50) classified as CNS-WHO grades 2–3. Tumor-adjacent cortex was immunohistochemically stained for b-A4, t-AT8, NeuN, APP, Ki67, and Iba1, and cells were quantified using Matlab and QuPath script. Longitudinal samples were available for 15 patients. Results: The median cell density in the tumor-adjacent cortex was significantly higher in glioma patients (astrocytoma: 1395/mm2, oligodendroglioma: 1492/mm2) compared to non-tumor cortex (1098/mm2, P < .0001). ADNC, including pTau (36%, N = 31/85) and Abeta (14%, N = 12/85), was observed in 38% (N = 32/85) of individuals. pTau and A beta positively correlated with age (Hazard ratio = 0.1, P = .02), tumor cell infiltration (Kendall’s tau = 0.100, P = 4.7*10−4), and diffuse axonal injury (P = .018). ADNC was commonly found in the temporal cortex (53%, N = 9/17). Conclusion: Our study reveals an unexpectedly high prevalence of ADNC, particularly isolated pTau deposits, in the tumor-adjacent cortex of younger individuals with IDH-mutant glioma. These findings suggest tumor-driven tau accumulation, prompting further research into potential long-term cognitive effects.Keywords
Funding Information
- Austrian Alzheimer society
This publication has 35 references indexed in Scilit:
- Overview and Findings from the Religious Orders StudyCurrent Alzheimer Research, 2012
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 YearsJournal of Neuropathology & Experimental Neurology, 2011
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsNature Reviews Drug Discovery, 2011
- Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study ExperienceJournal of Alzheimer’s Disease, 2011
- Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- Transmission and spreading of tauopathy in transgenic mouse brainNature Cell Biology, 2009
- The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample CharacteristicsNeuroepidemiology, 2008
- Diffusion Tensor Imaging Detects Clinically Important Axonal Damage after Mild Traumatic Brain Injury: A Pilot StudyJournal of Neurotrauma, 2007
- PET of Brain Amyloid and Tau in Mild Cognitive ImpairmentNew England Journal of Medicine, 2006
- Trials and tribulations of using β-amyloid precursor protein immunohistochemistry to evaluate traumatic brain injury in adultsForensic Science International, 2004